Evidence map›Paper›PMID 34285117›Full record

ArticleDiabetes2021

Modulation of Glucose Production by Central Insulin Requires IGF-1 Receptors in AgRP Neurons.

Gabriela Farias Quipildor, Kai Mao, Pedro J Beltran, Nir Barzilai, Derek M Huffman

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gabriela Farias QuipildorDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY.
Kai MaoDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY.
Pedro J BeltranOncology Research, Amgen Inc., Thousand Oaks, CA.
Nir BarzilaiInstitute for Aging Research, Albert Einstein College of Medicine, Bronx, NY.
Derek M HuffmanDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY derek.huffman@einsteinmed.org.ORCID 0000-0001-9520-3449
Albert Einstein College of Medicine · USAmgen (United States) · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI STEVEN C. ALMO · 1985 to 2026
$111.2M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
Einstein's Nathan Shock Center of Excellence in Basic Biology of AgingP30AG038072 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HUFFMAN, DEREK MAJOR · 2010 to 2024
$10.8M
Dysregulation of Glucose Homeostasis in AgingR37AG018381 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BARZILAI, NIR J · 2010 to 2019
$3.5M
Peripheral and central IGF-1 action in energy balance and longevity modulation R00AG037574 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HUFFMAN, DEREK MAJOR · 2013 to 2015
$732k
Advanced Confocal Microscope in a multi-user facilityS10OD023591 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BAKER, NICHOLAS E · 2017 to 2017
$590k
High-speed/resolution whole slide scanner supported by two core facilitiesS10OD019961 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CONDEELIS, JOHN S · 2015 to 2015
$326k
NCI NIH HHS P30 CA013330NIA NIH HHS P30 AG038072NIA NIH HHS R00 AG037574NIA NIH HHS R37 AG018381NIDDK NIH HHS P30 DK020541NIH HHS S10 OD019961NIH HHS S10 OD023591
6 · The paper itself

Abstract

Similar to insulin, central administration of IGF-1 can suppress hepatic glucose production (HGP), but it is unclear whether this effect is mediated via insulin receptors (InsRs) or IGF-1 receptors (IGF-1Rs) in the brain. To this end, we used pharmacologic and genetic approaches in combination with hyperinsulinemic-euglycemic clamps to decipher the role of these receptors in mediating central effects of IGF-1 and insulin on HGP. In rats, we observed that intracerebroventricular (ICV) administration of IGF-1 or insulin markedly increased the glucose infusion rate (GIR) by >50% and suppressed HGP (

Indexed as

AdultAgouti-Related ProteinAnimalsCarbohydrate MetabolismCells, CulturedGlucoseGlucose Clamp TechniqueHumansHypothalamusInjections, IntraventricularInsulinMaleMiceMice, Inbred C57BLMice, KnockoutNeuronsAgouti-Related ProteinGlucoseInsulinReceptor, IGF Type 1

Identifiers

PMID34285117
PMCPMC8928909
OpenAlexW3183589699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.